33.88
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| REGENXBIO Inc | RGNX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 1.34 | 4.12% | 33.88 | 30.23 | 34.56 | 30.97 | 32.54 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 26.00 | 34.80 | 8.80 | 25.29% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,709 | 567,945 | $ 32.36 | $ 18,380,814 | 639,551 | 20.03 - 59.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:56:07 | average | 20,530 | $ 33.88 | USD |
REGENXBIO Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 1.26B | 37.14M | $ 99.94M | -2.59 | - | 36.68M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
REGENXBIO News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGNX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 26.30 | 34.94 | 25.60 | 30.51 | 589,474 | 7.58 | 28.82% |
| 1 Month | 39.67 | 43.33 | 20.03 | 31.31 | 679,474 | -5.79 | -14.6% |
| 3 Months | 38.55 | 54.97 | 20.03 | 39.52 | 524,326 | -4.67 | -12.11% |
| 6 Months | 33.45 | 54.97 | 20.03 | 39.35 | 514,218 | 0.43 | 1.29% |
| 1 Year | 57.75 | 59.98 | 20.03 | 42.34 | 528,459 | -23.87 | -41.33% |
| 3 Years | 19.85 | 85.10 | 16.30 | 44.59 | 467,171 | 14.03 | 70.68% |
| 5 Years | 30.26 | 85.10 | 7.0701 | 40.38 | 368,976 | 3.62 | 11.96% |
REGENXBIO Description
| Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). |
